Vectura prevails in US patent litigation with GSK The Pharma Letter
UK developer of inhaled therapies Vectura (LSE:VEC) confirmed over the weekend that, on May 3, 2019, following a jury trial in the US District Court for the …
Vectura prevails in US patent litigation with GSK The Pharma Letter
UK developer of inhaled therapies Vectura (LSE:VEC) confirmed over the weekend that, on May 3, 2019, following a jury trial in the US District Court for the …